Skip to content
2000
Volume 21, Issue 4
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Hypertrophic cardiomyopathy (HCM) is an inherited disorder of cardiac sarcomeric proteins characterised by the presence of myocardial hypertrophy in the absence of abnormal loading conditions. Individuals with HCM can remain asymptomatic throughout their lives but many experience chest pain, symptoms of heart failure, syncope and sudden ventricular arrhythmias. Cardiopulmonary exercise testing is an important part of the assessment of patients with HCM who often have reduced peak oxygen consumption and a lower anaerobic threshold compared with healthy age-matched controls. This review will focus on mechanisms of exercise limitation, which are complex and multifactorial, and the options for medical management.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161282104141204142436
2015-02-01
2024-10-15
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161282104141204142436
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test